These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25134821)

  • 21. Genes Controlled by DNA Methylation Are Involved in Wilms Tumor Progression.
    Guerra JVDS; Pereira BMS; Cruz JGVD; Scherer NM; Furtado C; Montalvão de Azevedo R; Oliveira PSL; Faria P; Boroni M; de Camargo B; Maschietto M
    Cells; 2019 Aug; 8(8):. PubMed ID: 31426508
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The DNA methylation landscape of five pediatric-tumor types.
    Parker AC; Quinteros BI; Piccolo SR
    PeerJ; 2022; 10():e13516. PubMed ID: 35707123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of promoter methylation and expression of SIX2 as a diagnostic and prognostic biomarker in Wilms' tumor.
    Song D; Yue L; Wu G; Ma S; Guo L; Yang H; Liu Q; Zhang D; Xia Z; Wang L; Zhang J; Zhao W; Guo F; Wang J
    Tumour Biol; 2015 Sep; 36(10):7591-8. PubMed ID: 25921281
    [TBL] [Abstract][Full Text] [Related]  

  • 24. WT1 mutation and 11P15 loss of heterozygosity predict relapse in very low-risk wilms tumors treated with surgery alone: a children's oncology group study.
    Perlman EJ; Grundy PE; Anderson JR; Jennings LJ; Green DM; Dome JS; Shamberger RC; Ruteshouser EC; Huff V
    J Clin Oncol; 2011 Feb; 29(6):698-703. PubMed ID: 21189373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cord blood DNA methylome in newborns later diagnosed with autism spectrum disorder reflects early dysregulation of neurodevelopmental and X-linked genes.
    Mordaunt CE; Jianu JM; Laufer BI; Zhu Y; Hwang H; Dunaway KW; Bakulski KM; Feinberg JI; Volk HE; Lyall K; Croen LA; Newschaffer CJ; Ozonoff S; Hertz-Picciotto I; Fallin MD; Schmidt RJ; LaSalle JM
    Genome Med; 2020 Oct; 12(1):88. PubMed ID: 33054850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isochromosome 7q in adult Wilms' tumors: diagnostic and pathogenetic implications.
    Rubin BP; Pins MR; Nielsen GP; Rosen S; Hsi BL; Fletcher JA; Renshaw AA
    Am J Surg Pathol; 2000 Dec; 24(12):1663-9. PubMed ID: 11117788
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amplification and overexpression of CACNA1E correlates with relapse in favorable histology Wilms' tumors.
    Natrajan R; Little SE; Reis-Filho JS; Hing L; Messahel B; Grundy PE; Dome JS; Schneider T; Vujanic GM; Pritchard-Jones K; Jones C
    Clin Cancer Res; 2006 Dec; 12(24):7284-93. PubMed ID: 17189400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The IGF signalling pathway in Wilms tumours--a report from the ENCCA Renal Tumours Biology-driven drug development workshop.
    Maschietto M; Charlton J; Perotti D; Radice P; Geller JI; Pritchard-Jones K; Weeks M
    Oncotarget; 2014 Sep; 5(18):8014-26. PubMed ID: 25478630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessment of somatic mutations in urine and plasma of Wilms tumor patients.
    Miguez ACK; Barros BDF; de Souza JES; da Costa CML; Cunha IW; Barbosa PNVP; Apezzato MLP; de Souza SJ; Carraro DM
    Cancer Med; 2020 Aug; 9(16):5948-5959. PubMed ID: 32592321
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Altered expression of imprinted genes in Wilms tumors.
    Hubertus J; Lacher M; Rottenkolber M; Müller-Höcker J; Berger M; Stehr M; von Schweinitz D; Kappler R
    Oncol Rep; 2011 Mar; 25(3):817-23. PubMed ID: 21174059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CITED1 expression in Wilms' tumor and embryonic kidney.
    Lovvorn HN; Westrup J; Opperman S; Boyle S; Shi G; Anderson J; Perlman EJ; Perantoni AO; Wills M; de Caestecker M
    Neoplasia; 2007 Jul; 9(7):589-600. PubMed ID: 17710162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The genetic changes of Wilms tumour.
    Treger TD; Chowdhury T; Pritchard-Jones K; Behjati S
    Nat Rev Nephrol; 2019 Apr; 15(4):240-251. PubMed ID: 30705419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of the RNA component of telomerase in Wilms tumor and nephrogenic rest recapitulates renal embryogenesis.
    Yashima K; Maitra A; Timmons CF; Rogers BB; Pinar H; Shay JW; Gazdar AF
    Hum Pathol; 1998 May; 29(5):536-42. PubMed ID: 9596280
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Intra-Tumor Genetic Heterogeneity in Wilms Tumor: Clonal Evolution and Clinical Implications.
    Cresswell GD; Apps JR; Chagtai T; Mifsud B; Bentley CC; Maschietto M; Popov SD; Weeks ME; Olsen ØE; Sebire NJ; Pritchard-Jones K; Luscombe NM; Williams RD; Mifsud W
    EBioMedicine; 2016 Jul; 9():120-129. PubMed ID: 27333041
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinically relevant subsets identified by gene expression patterns support a revised ontogenic model of Wilms tumor: a Children's Oncology Group Study.
    Gadd S; Huff V; Huang CC; Ruteshouser EC; Dome JS; Grundy PE; Breslow N; Jennings L; Green DM; Beckwith JB; Perlman EJ
    Neoplasia; 2012 Aug; 14(8):742-56. PubMed ID: 22952427
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Germline mutations and somatic inactivation of TRIM28 in Wilms tumour.
    Halliday BJ; Fukuzawa R; Markie DM; Grundy RG; Ludgate JL; Black MA; Skeen JE; Weeks RJ; Catchpoole DR; Roberts AGK; Reeve AE; Morison IM
    PLoS Genet; 2018 Jun; 14(6):e1007399. PubMed ID: 29912901
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The yin and yang of kidney development and Wilms' tumors.
    Hohenstein P; Pritchard-Jones K; Charlton J
    Genes Dev; 2015 Mar; 29(5):467-82. PubMed ID: 25737276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Single-nucleotide polymorphism in WT1 gene in a hyperplastic intralobar nephrogenic rest with botryoid protrusion.
    Mizuno K; Hayashi Y; Tozawa K; Iwatsuki S; Kojima Y; Kohri K
    Urology; 2010 Jul; 76(1):149-52. PubMed ID: 19914700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: a report from the National Wilms Tumor Study Group.
    Grundy PE; Breslow NE; Li S; Perlman E; Beckwith JB; Ritchey ML; Shamberger RC; Haase GM; D'Angio GJ; Donaldson M; Coppes MJ; Malogolowkin M; Shearer P; Thomas PR; Macklis R; Tomlinson G; Huff V; Green DM;
    J Clin Oncol; 2005 Oct; 23(29):7312-21. PubMed ID: 16129848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Biomarkers to detect Wilms tumors in pediatric patients: where are we now?
    Charlton J; Pavasovic V; Pritchard-Jones K
    Future Oncol; 2015; 11(15):2221-34. PubMed ID: 26235184
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.